They may even suggest alternative approaches
le Roux provides obesity clinical care in the Beyond BMI clinic and is a shareholder in the clinic
This study supports the hypothesis that GLP-1 receptor agonists may reduce the symptom burden in fibromyalgia patients, particularly with regard to opioid dependency, fatigue and pain, wrote Nouran Eshak, MB, ChB, rheumatology fellow at Mayo Clinic and the lead investigator of the study
doi: 10.1016/j.dsx.2025.103212, 17
This section provides information about: Managed cares role in administering pharmacy benefits Pharmacy cost containment Coverage of obesity drugs Box 3: CMSs Cell and Gene Therapy (CGT) Access Model In 2023, CMS established the Cell and Gene Therapy (CGT) Access Model, which is a voluntary, multi-year model designed to develop outcomes-based agreements between states and manufacturers to improve access and reduce costs of new innovative therapies